|
1
|
Itoh T, Saito T, Yamamoto Y, Ishida H, Yamamoto K. Gram scale synthesis of specialized pro-resolving mediator 17(S)-HDHA using lipoxygenase enhanced by water-soluble reducing agent TCEP. Bioorg Med Chem Lett 2016; 26:343-345. [PMID: 26707393 DOI: 10.1016/j.bmcl.2015.12.011] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2015] [Revised: 11/22/2015] [Accepted: 12/04/2015] [Indexed: 12/31/2022]
Abstract
17(S)-Hydroxy docosahexaenoic acid (17(S)-HDHA) is a specialized pro-resolving mediator. The oxidation of docosahexaenoic acid (DHA) to 17(S)-HDHA using soybean lipoxygenase was accomplished in the presence of the reducing agent TCEP in high yield and high enantio excess. We demonstrated application of this strategy to the synthesis of other fatty acids and to gram scale synthesis of 17(S)-HDHA.
Collapse
Affiliation(s)
- Toshimasa Itoh
- Laboratory of Drug Design and Medicinal Chemistry, Showa Pharmaceutical University, 3-3165 Higashi-Tamagawagakuen, Machida, Tokyo 194-8543, Japan
| | - Tomoko Saito
- Laboratory of Drug Design and Medicinal Chemistry, Showa Pharmaceutical University, 3-3165 Higashi-Tamagawagakuen, Machida, Tokyo 194-8543, Japan
| | - Yoshinori Yamamoto
- Laboratory of Drug Design and Medicinal Chemistry, Showa Pharmaceutical University, 3-3165 Higashi-Tamagawagakuen, Machida, Tokyo 194-8543, Japan
| | - Hiroaki Ishida
- Laboratory of Drug Design and Medicinal Chemistry, Showa Pharmaceutical University, 3-3165 Higashi-Tamagawagakuen, Machida, Tokyo 194-8543, Japan
| | - Keiko Yamamoto
- Laboratory of Drug Design and Medicinal Chemistry, Showa Pharmaceutical University, 3-3165 Higashi-Tamagawagakuen, Machida, Tokyo 194-8543, Japan.
| |
Collapse
|
|
2
|
Conrow RE, Harrison P, Jackson M, Jones S, Kronig C, Lennon IC, Simmonds S. Manufacture of (5Z,8Z,11Z,13E)(15S)-15-Hydroxyeicosa-5,8,11,13-tetraenoic Acid Sodium Salt for Clinical Trials. Org Process Res Dev 2010. [DOI: 10.1021/op100244n] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Raymond E. Conrow
- Dr. Reddy’s Custom Pharmaceutical Services, Chirotech Technology Limited, Unit 162 Cambridge Science Park, Milton Road, Cambridge CB4 0GH, U.K., and Alcon Laboratories, 6201 South Freeway, Fort Worth, Texas 76134, United States
| | - Paul Harrison
- Dr. Reddy’s Custom Pharmaceutical Services, Chirotech Technology Limited, Unit 162 Cambridge Science Park, Milton Road, Cambridge CB4 0GH, U.K., and Alcon Laboratories, 6201 South Freeway, Fort Worth, Texas 76134, United States
| | - Mark Jackson
- Dr. Reddy’s Custom Pharmaceutical Services, Chirotech Technology Limited, Unit 162 Cambridge Science Park, Milton Road, Cambridge CB4 0GH, U.K., and Alcon Laboratories, 6201 South Freeway, Fort Worth, Texas 76134, United States
| | - Shaun Jones
- Dr. Reddy’s Custom Pharmaceutical Services, Chirotech Technology Limited, Unit 162 Cambridge Science Park, Milton Road, Cambridge CB4 0GH, U.K., and Alcon Laboratories, 6201 South Freeway, Fort Worth, Texas 76134, United States
| | - Christel Kronig
- Dr. Reddy’s Custom Pharmaceutical Services, Chirotech Technology Limited, Unit 162 Cambridge Science Park, Milton Road, Cambridge CB4 0GH, U.K., and Alcon Laboratories, 6201 South Freeway, Fort Worth, Texas 76134, United States
| | - Ian C. Lennon
- Dr. Reddy’s Custom Pharmaceutical Services, Chirotech Technology Limited, Unit 162 Cambridge Science Park, Milton Road, Cambridge CB4 0GH, U.K., and Alcon Laboratories, 6201 South Freeway, Fort Worth, Texas 76134, United States
| | - Shaun Simmonds
- Dr. Reddy’s Custom Pharmaceutical Services, Chirotech Technology Limited, Unit 162 Cambridge Science Park, Milton Road, Cambridge CB4 0GH, U.K., and Alcon Laboratories, 6201 South Freeway, Fort Worth, Texas 76134, United States
| |
Collapse
|
|
4
|
Iacazio G, Martini D, Faure B, N'Guyen MH. Isolation and characterisation of 8-hydroxy-3Z,5Z-tetradecadienoic acid, a putative intermediate in Pichia guilliermondii gamma-decalactone biosynthesis from ricinoleic acid. FEMS Microbiol Lett 2002; 209:57-62. [PMID: 12007654 DOI: 10.1111/j.1574-6968.2002.tb11109.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
During a screening procedure for the discovery of a strong gamma-decalactone producer from ricinoleic acid, we observed that the yeast Pichia guilliermondii accumulated transiently 8-hydroxy-3Z,5Z-tetradecadienoic acid 1 during gamma-decalactone biosynthesis in the stationary phase of growth. The structural elucidation of 1 was based on nuclear magnetic resonance, infrared, ultraviolet and gas chromatography-mass spectrometry experiments. The occurrence of 1 is discussed in relation with previously proposed gamma-decalactone biosynthetic pathways.
Collapse
Affiliation(s)
- G Iacazio
- Laboratoire de Microbiologie, UMR-CNRS 6116, Faculté des Sciences de Saint Jérôme, case 452, Av. Escadrille Normandie-Niemen, 13397 Marseille Cedex 20, France.
| | | | | | | |
Collapse
|
|
6
|
Gill I, Valivety R. Polyunsaturated fatty acids, Part 2: Biotransformations and biotechnological applications. Trends Biotechnol 1997; 15:470-8. [PMID: 9369030 DOI: 10.1016/s0167-7799(97)01077-9] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
The realization of the important biomedical roles of polyunsaturated fatty acids has led to the development of methods for obtaining and manipulating polyunsaturated lipids. Enzyme-mediated reactions have demonstrated unique advantages over chemical approaches and commercial lipase- and phospholipase-catalysed processes have been developed to address the mid- to high-value polyunsaturated-lipid market. Research over the past two decades has also highlighted the broad spectrum of bioactive products derived from the oxidation of polyunsaturated fatty acids. The potential of these compounds in the flavour, fragrance, pharmaceutical and fine-chemical arenas has encouraged the elaboration of biotransformation strategies based on isolated enzymes and whole cells.
Collapse
Affiliation(s)
- I Gill
- Biotechnology Department, Firmenich SA, Corporate Research, Geneve, Switzerland.
| | | |
Collapse
|